{
    "nct_id": "NCT03388619",
    "official_title": "A Phase I Trial of Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy",
    "inclusion_criteria": "* INCLUSION CRITERIA:\n* Patients must have histologically or cytologically confirmed adenocarcinoma of the prostate.\n* Indications for post-prostatectomy radiation exist:\n\n  * Disease progression (detectable prostate-specific antigen (PSA) on two measurements obtained at least one month apart) or\n  * indications for adjuvant radiation exist (if undetectable PSA): pathologic T3, T4, N+ disease or positive margins (within 1 year of prostatectomy).\n* Age greater than or equal to 18 years.\n* Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 1 (Karnofsky greater than or equal to 60)\n* Ability of subject to understand and the willingness to sign a written informed consent document.\n* Radiation is teratogenic; thus, men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation and up to 120 days after the last radiation. Should a woman become pregnant or suspect she is pregnant while her partner is participating in this study, she should inform her treating physician immediately.\n* Human immunodeficiency virus (HIV) positive patients are included if CD4+ (cytotoxic T cells) T-cell count > 200 cells/uL; on stable antiretroviral therapy for > 1 year with HIV viral load <200 copies/mL, and no history of opportunistic infections in > 1 year.\n\nEXCLUSION CRITERIA:\n\n* Patients who are receiving any other investigational agents concurrently.\n* Documented metastases of prostate cancer outside of the pelvis (pelvic lymph nodes are allowed only if within the prostate bed region).\n* History of radiation that would overlap with the intended treatment to the prostate bed.\n* Known contraindications to radiation such as inflammatory bowel disease, active systemic lupus or scleroderma, or radiation hypersensitivity syndrome (Ataxia Telangiectasia or Fanconi's Anemia)\n* Subjects with any coexisting medical or psychiatric condition which, in the opinion of the Investigator likely to interfere with study procedures and/or results.\n* Medically indicated use of known radiosensitizing drugs (such as protease inhibitors)\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}